People with mutations in the enzymes that form glutathione are more susceptible to oxidative stress
We also have some tips for you
Cardiovascular Risk Reduction Benefits of GLP-1 RAs for Your Patients With Obesity, Without T2D high risk for cardiovascular disease
LaPelusa, A., & Kaushik, R
According to Ricardo Correa, the endocrinology fellowship director at the University of Arizona College of Medicine , compound pharmacies "are probably using the same active pharmacological part [semaglutide], but when you combine things and you add different excipients, the effectivenessif you don't measure that in a randomized controlled trialwill not be the same." "I can tell you, the consensus amongst legitimate practicing obesity endocrinology specialists is to avoid this, because it's just too much unknown," Nadolsky said
It's important to note that while these medications are licensed for BMI 30 kg/m or 27 kg/m with weight-related comorbidities, NHS access typically follows stricter NICE criteria and usually requires initiation through specialist weight management services